Sofinnova Investments, Inc. Aerovate Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 3,758,686 shares of AVTE stock, worth $8.87 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
3,758,686
Previous 3,758,686
-0.0%
Holding current value
$8.87 Million
Previous $111 Million
94.39%
% of portfolio
0.35%
Previous 6.47%
Shares
1 transactions
Others Institutions Holding AVTE
# of Institutions
93Shares Held
27.6MCall Options Held
185KPut Options Held
129K-
Ra Capital Management, L.P. Boston, MA9.19MShares$21.7 Million0.23% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$5.29 Million0.56% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.25 Million0.4% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$3.33 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$2.61 Million0.0% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $57.7M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...